Skip to main content

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Please see our latest guidance on face masks.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Myeloproliferative neoplasm (M85)

Molecular investigations

Detection of the BCR-ABL fusion gene - screen for the presence of BCR-ABL fusion transcripts using multiplex PCR.

JAK2 V617F - targeted analysis by allele specific PCR and pyrosequencing. Appropriate samples are forwarded to the Wessex Genetics Laboratory for analysis of the MPN panel.

Myeloid panel (multi-target NGS panel (small variant)).


As outlined in the Test Directory.


As outlined in the Test Directory other than tests M85.10, M85.28, M85.32 & M85.33 - if any of these tests are required please contact us to discuss forwarding the sample elsewhere.

Last reviewed:02 August 2021